We present the Neuroimmunology Drug Development Summit, the industry’s definitive and unrivalled forum focused on pushing the frontiers of targeting neuroinflammation for CNS Indications.

As diverse programs are advancing towards the clinic, there is a dire need to tackle the many translational challenges neuro-immunologists are facing to develop clinically effective neuroimmunology targeted therapeutics.

Building on the success of last year’s meeting, this year’s program will uncover how leading companies in this emerging field are discovering immune-modulating targets and deploying immuno-neurology across clinical case studies. As we gather the best minds in this infant field we will put a spotlight on the latest key learnings across microglia, astrocytes, STING, TREM2 and more to help pave the way to translating key technological and mechanistic insights towards the clinic.

Join this intimate, industry led forum to not only learn from those pioneering the field, but to network and build meaningful partnerships with 80+ neuroimmunology drug development experts.